Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2009-01-27 (17 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: MARTIGNAS-SUR-JALLE (33127), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EURL MEDICAL THIRY : revenue, balance sheet and financial ratios
EURL MEDICAL THIRY is a French company
founded 17 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in MARTIGNAS-SUR-JALLE (33127),
this company of category PME
shows in 2021 a net income positive of 98 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EURL MEDICAL THIRY (SIREN 510155690)
Indicator
2021
2020
2019
Revenue
N/C
N/C
N/C
Net income
97 533 €
72 €
5 354 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2021, EURL MEDICAL THIRY generates positive net income of 98 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2021: 5 k€ -> 98 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
97 533 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
30.568%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.671%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
Debt ratio
65.418
45.879
30.568
Financial autonomy
31.927
33.604
37.671
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
30.572021
2019
2020
2021
Q1: 0.0
Med: 8.28
Q3: 63.33
Average-15 pts over 3 years
In 2021, the debt ratio of EURL MEDICAL THIRY (30.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.67%2021
2019
2020
2021
Q1: 16.51%
Med: 37.11%
Q3: 57.43%
Good+6 pts over 3 years
In 2021, the financial autonomy of EURL MEDICAL THIRY (37.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 80.09. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
80.095
Liquidity indicators evolution EURL MEDICAL THIRY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
Liquidity ratio
100.147
92.378
80.095
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
80.092021
2019
2020
2021
Q1: 139.0
Med: 204.34
Q3: 325.42
Watch
In 2021, the liquidity ratio of EURL MEDICAL THIRY (80.09) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of EURL MEDICAL THIRY in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Indicative estimate only : the number of comparable transactions in this sector is limited (21 transactions).
This range of 17 917€ to 109 903€ is provided for information purposes only and requires in-depth analysis to be confirmed.
Estimated enterprise value2021
Indicative
17k€41k€109k€
41 223 €Range: 17 917€ - 109 903€
NAF 5 année 2021
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 21 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare EURL MEDICAL THIRY with other companies in the same sector:
Frequently asked questions about EURL MEDICAL THIRY
What is the revenue of EURL MEDICAL THIRY ?
The revenue of EURL MEDICAL THIRY is not publicly disclosed (confidential accounts filed with INPI).
Is EURL MEDICAL THIRY profitable?
Yes, EURL MEDICAL THIRY generated a net profit of 98 k€ in 2021.
Where is the headquarters of EURL MEDICAL THIRY ?
The headquarters of EURL MEDICAL THIRY is located in MARTIGNAS-SUR-JALLE (33127), in the department Gironde.
Where to find the tax return of EURL MEDICAL THIRY ?
The tax return of EURL MEDICAL THIRY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EURL MEDICAL THIRY operate?
EURL MEDICAL THIRY operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart